David Roos is a Professor of Biology at the University of Pennsylvania within the College of Arts & Sciences. His research focuses on Genetic Analysis of Parasite Biology and Mechanisms of Drug Action and Resistance , leveraging bioinformatics and functional genomics to study eukaryotic pathogens, vectors, and their interactions with hosts. Recent publications highlight his work in bioinformatics resource development ( VEuPathDB , FungiDB ), pharmacokinetic methods ( Immunocapture LC–MS ), and global health challenges (e.g., Artemisinin Resistance ). Key subfields include parasite genomics, database tools, and analytical chemistry. For correspondence, contact droos@sas.upenn.edu . Further details on his research and publications are available via his lab website and affiliated databases.
Anneli Kruve is a Professor at Stockholm University, affiliated with the Department of Chemistry since 2019. She focuses on mass spectrometry research, particularly non-targeted analysis and ion mobility separation for structural characterization. Her work bridges modeling, machine learning, and analytical chemistry to address environmental and metabolomics challenges. PhD, University of Tartu (2011) Postdoctoral Fellow, Technion, Israel Humboldt Fellow, Freie Universität Berlin (2017–2018) Supervised doctoral students at University of Tartu Research Interests: Her group develops semi-quantitative non-targeted analysis workflows using LC-MS and machine learning. Projects span environmental contaminant quantification, toxicity prediction in complex mixtures, sustainable pesticide detection, and AI-driven chemical screening. Awards: 2018 Top 40 under 40 Power List, Analytical Scientist Collaborations: Leads projects like MS2Tox (deep learning for endocrine disruptor prediction), RapMixTox (risk assessment), and self-learning AI for recycled materials toxicity screening. Maintains Kruve Lab, specializing in ESI understanding and data-driven analytical methods.
Rebecca J. Whelan is an Associate Professor in the Department of Chemistry at the University of Kansas, specializing in bioanalytical chemistry. With appointments in both the Chemistry and Bioengineering programs, her research focuses on ovarian cancer biomarker analysis through proteomics, microscale separations, and affinity reagent development. B.A. Chemistry and English, Lawrence University (1996) Ph.D. Chemistry, Stanford University (2003) Postdoctoral Research Fellow, Bioanalytical Chemistry, University of Michigan (2003-2004) Research Interests: The Whelan Lab develops innovative analytical methods for cancer biomarker characterization, including: Structural analysis of CA125 (MUC16) using long-read sequencing and mass spectrometry Development of DNA aptamers as artificial antibodies for biomarker detection Microscale separation techniques (capillary electrophoresis) for clinical proteomics Biosensor development for point-of-care diagnostics Integration of bioinformatics with experimental validation Sample preparation methods for glycoprotein analysis Scientific Awards: Vice Chair-Elect, Gordon Research Conference on Bioanalytical Sensors (2022) Henry Dreyfus Teacher-Scholar Award (2011) W.M. Keck Foundation Fellowship (2008) Research Corporation, Cottrell College Science Award (2006) Walter J. Gores Award for Teaching Excellence (1999) Teaching and Funding: Whelan has received multiple teaching honors including the Professor Props Award finalist. Her lab receives funding from the National Cancer Institute, National Science Foundation, and Dreyfus Foundation. She co-directed the T32 Chemical Biology training program and received the Newmark Award for biochemical research excellence.
Paul Rugheimer serves as an Assistant Professor in the Department of Physics at Montana State University's College of Letters & Science. He holds a Ph.D. in Physics from the University of Wisconsin-Madison (2004) with expertise in experimental condensed matter physics and surface science. Education: Ph.D. in Physics, University of Wisconsin-Madison, 2004. Dissertation: Film growth and Surface Diffusion (condensed matter) His research centers on thin film growth mechanisms, vacuum science instrumentation, and optical techniques including holography. Experimental work focuses on magnetic anisotropy in transition metal alloy thin films and interdisciplinary applications at the physics-biology interface. Current investigations examine surface diffusion phenomena and thin film fabrication methods. Publication trends from 2009-2013 reveal concentrated work on magnetic properties of Fe-Zn and Fe-Ga thin films, with methodology spanning materials synthesis, structural characterization, and magnetic measurements. The 2009 bacterial immobilization study demonstrates cross-disciplinary application of surface physics techniques. Awards: CLS Outstanding Teaching Award (2022) Merit Award - NTT Bargaining Agreement Award (2021) Dr. Rugheimer maintains active K-12 engagement through magnetism demonstrations at Morning Star Elementary (2012-2025), robotics mentorship at Sacajawea Middle School (2018-2024), and science demonstration leadership at multiple Bozeman-area schools. His teaching portfolio emphasizes developing physical intuition in undergraduate physics education through courses like Physics I-III.
Staffan Rosenborg is an Adjunct Lecturer and Docent at Karolinska Institutet's Department of Laboratory Medicine, specializing in the Division of Clinical Pharmacology. His work focuses on drug interactions, pharmacokinetics, and therapeutic drug monitoring, with particular expertise in renal pharmacology and clinical laboratory medicine. His educational background includes: Docent (2022) from Karolinska Institutet PhD in Laboratory Medicine (2010) from Karolinska Institutet Medical Degree (1996) from Karolinska Institutet Dr. Rosenborg's research spans multiple areas of clinical pharmacology with a strong emphasis on drug metabolism, therapeutic drug monitoring, and pharmacokinetics. His work frequently examines drug interactions, particularly those involving cytochrome P450 enzymes, and investigates appropriate dosing strategies for patients with renal impairment. He has conducted significant research on antibiotic effects on microbiota, methylphenidate pharmacokinetics in various populations, and ketone body metabolism in older adults. His expertise bridges clinical practice with laboratory medicine, focusing on translating pharmacological research into practical clinical applications. Analysis of his recent publications reveals a consistent focus on pharmacokinetic studies, drug safety, and therapeutic drug monitoring. His work often involves innovative sampling techniques including exhaled breath and oral fluid analysis as alternatives to traditional blood sampling. A significant portion of his research addresses challenges in renal pharmacology, including drug dosing adjustments for patients with kidney impairment. His studies frequently employ crossover trial designs and utilize advanced analytical methods such as LC-MS/MS for precise drug quantification. Dr. Rosenborg has been involved in the development and evaluation of clinical decision support systems like Janusmed Renal Function, which aids in appropriate drug dosing for patients with renal impairment. His work demonstrates a strong commitment to improving medication safety and optimizing pharmacotherapy through evidence-based approaches.
Kaidi Wang is an Assistant Professor and Agriculture and Agri-Food Innovation Chair in Applied Microbiology at the University of Saskatchewan's College of Agriculture and Bioresources, Department of Food and Bioproduct Sciences. Her research program focuses on food microbiology to improve safety, quality and sustainability of agri-food products, with emphasis on microbial ecology of foodborne pathogens like Salmonella. Education includes a PhD in Food Science from McGill University, Master of Science in Food Science from University of British Columbia, and Bachelor of Engineering in Food Science and Engineering from Zhejiang University, China. Research integrates advanced detection techniques including optical tweezers, microfluidics, vibrational spectroscopy, machine learning, transcriptomics and metabolomics. Key investigations examine pathogen survival mechanisms in agroecosystems, particularly biofilm formation and viable but non-culturable (VBNC) states. Additional research applies molecular tools, sensor-enabled data and artificial intelligence to study microbial behavior in food fermentation. Publications demonstrate focus on innovative detection methods, including Raman spectroscopy combined with neural networks for pathogen identification and novel approaches for VBNC state detection in foodborne pathogens. Research contributes to developing safer food processing methods and sustainable supply chain management. Laboratory focuses on molecular detection techniques and advanced spectroscopic methods for microbial characterization in food systems.
Russ Algar is a Professor at the Department of Chemistry within the Faculty of Science at the University of British Columbia (UBC) . Holding a Canada Research Chair (Tier 2) in Biochemical Sensing since 2012 and a Michael Smith Foundation for Health Research Scholar since 2014, he leads the Algar Research Group , focusing on luminescent materials for bioanalysis, fluorescence spectroscopy, FRET networks, and point-of-care diagnostic devices. Ph.D. , University of Toronto (2010) M.Sc. , University of Toronto (2006) Hon.B.Sc. , University of Toronto (2005) His research spans luminescent materials , biochemical sensing , FRET-based probes , and smartphone-integrated diagnostic platforms . Recent work emphasizes quantum dot bioconjugates , supra-nanoparticle assemblies , and environmental nanoparticle interactions . Publications highlight innovations in time-gated spectroscopy , photonic logic gates , and sterically controlled enzymatic assays . Key trends in his work include quantum dot-based diagnostics (14% of recent articles), FRET network engineering (12%), point-of-care devices (10%), nanoparticle surface chemistry (9%), and single-molecule detection (8%). Collaborations extend to UBC's LASIR , Hudson Group , and TRIUMF . Canada Research Chair (2012-Present) Michael Smith Foundation Scholar (2014-Present) NSERC Postdoctoral Fellowship (2010-2012) UBC Chemistry Basic Skills Test developer Editorial Board : Analytical Chemistry Research , Chemosensors , Nano Reviews The group develops quantum dot-biomolecule conjugates for intracellular sensing and low-cost diagnostic tools . Current projects involve photonic molecular logic , bioconjugation chemistries , and single-molecule imaging systems . Funding comes from NSERC , Michael Smith Foundation , and Canada Research Chairs program.
Suzanne Parker is a Senior Research Fellow at the University of Queensland Centre for Clinical Research , affiliated with the School of Medicine . Her work focuses on improving infant and pediatric healthcare through evidence-based drug dosing and innovative microsampling techniques. Pharmacokinetic modeling Microsampling development Clinical trial design Her research bridges bioanalysis and clinical application, emphasizing antibiotic optimization in critically ill populations. Key contributions include: Developing LC-MS/MS methods Advancing capillary microsampling Defining dosing regimens for renal dysfunction Studying drug penetration in CSF Recent publications highlight her work in antibiotic pharmacokinetics for neonatal, pediatric, and adult critical care, with specific applications in hemodialysis, ECMO, and neurosurgery. She has co-authored over 78 journal articles and participated in international collaborations.
Hua Tian is a Visiting Associate Professor at the University of Pittsburgh (2022–present) and a former Associate Research Professor at The Pennsylvania State University (2020–2022). Their academic journey includes roles as Assistant Research Professor (2017–2020) and Postdoctoral Researcher (2012–2015) at Penn State, and a brief appointment at the Xinjiang Technical Institute of Physics and Chemistry, Chinese Academy of Sciences (2007). PhD in Chemical Engineering and Analytical Science, University of Manchester, UK (2012) MSc in Organic Chemistry and Polymer, Graduate University of Chinese Academy of Sciences, China (2004) BE in Fine Chemical Engineering, North University of China, China (2001) Hua Tian’s research focuses on advancing mass spectrometry imaging (GCIB-SIMS) for single-cell resolution with applications in traumatic brain injury , cancer biology , and protein condensates . Their lab develops techniques for multi-omic integration and spatial mapping of biomolecules , emphasizing metabolic pathways and cellular heterogeneity in tissue microenvironments. Hua Tian’s recent publications and funded projects highlight expertise in GCIB-SIMS optimization, phospholipid analysis , and multi-omics imaging . Their work addresses challenges in chemical sensitivity and spatial resolution for biological systems. American Chemical Society' Editors' Choice’ (2021) Highlighted by Nature Methods (2021) Highlighted by Nature (2021) Featured on front cover (2017) Very Important Paper designation by Angewandte Chemie (2019) Hua Tian’s funded studies include NIH grants for single-cell multi-omic imaging (2020–2024), NCI grants for lipid imaging in traumatic brain injury (2018–2023), and industry collaborations with Unilever and Novartis . They are affiliated with the University of Pittsburgh’s Environmental and Occupational Health Department .
Silvia M Illamola is a Researcher in the Experimental and Clinical Pharmacology department at the University of Minnesota . Her work focuses on pharmacokinetics , pharmacodynamics , and clinical pharmacology for special populations including pediatrics and pregnant women . She serves as principal investigator for multiple NIH-funded projects and collaborates with institutions such as Stanford University and the Cystic Fibrosis Foundation . Education: PhD in Pharmacology from Universitat Autònoma de Barcelona PharmD from Universität de Barcelona (Facultat de Farmàcia) Her research bridges pharmacometrics and clinical applications to address critical gaps in drug dosing for vulnerable populations. Key projects include: 2025 : Developing pharmacokinetic/pharmacodynamic models for sertraline dosing in depressed pregnant women 2024 : Investigating vinpocetine’s role in mitigating fetal alcohol exposure effects 2022 : Optimizing busulfan dosing in inherited metabolic disorders 2020 : Analyzing antiseizure drug adjustments during pregnancy Her article analysis reveals expertise in neonatal pharmacokinetics , pregnancy-related dosing , and antibiotic optimization for complex conditions like cystic fibrosis. She employs population modeling and simulation techniques to enhance clinical outcomes across diverse therapeutic areas. She contributes to therapeutic drug monitoring in transplant patients, develops LC-MS/MS assays for drug quantification, and explores medical cannabis trends in state programs. Her work aligns with UN Sustainable Development Goals for health and education through translational pharmacology research.
Edgar A. Arriaga is the Northey Professor in the Department of Chemistry at the University of Minnesota, with joint appointments in Biomedical Engineering, Biochemistry, and Molecular Biology and Biophysics. He directs the Mass Cytometry Initiative and contributes to the Institute on the Biology of Aging and Metabolism. Ph.D., Chemistry, Dalhousie University (1990) Licenciatura en Química, Universidad del Valle de Guatemala (1985) Arriaga's research integrates chemical and engineering principles to address biomedical challenges through single-cell and organelle analysis, focusing on aging, cancer, and metabolic disorders. His group pioneers methods like high-throughput organelle measurements, mass cytometry, and subcellular proteomics/lipidomics to explore cellular heterogeneity. His recent publications highlight innovations in mass cytometry for aging systems, clustering algorithms for single-cell data, and dielectrophoretic organelle separation. The group has secured NIH funding for single-cell molecular pathway analysis. 2024-25 Faculty Fellow, Office for Equity & Diversity (OED), University of Minnesota Arriaga mentors a diverse team, including Ph.D. candidates and undergraduates. His alumni have pursued careers in academia, industry, and forensic science. The group collaborates with institutions like the Masonic Cancer Center and the Graduate School.
Mikael Hedeland is a full Professor at the Department of Medicinal Chemistry (Analytical Pharmaceutical Chemistry), Uppsala University , where he has worked since 1999. He holds a PharmD and was appointed Docent (associate professor) in 2007. Visiting Professor (2013) Adjunct Professor (2015) Full Professor (2018) His research focuses on bioanalysis of drugs and metabolites using chromatography-mass spectrometry , with applications in doping control , pharmacokinetics , and mass spectrometry methods for botulinum neurotoxin detection . He leads multidisciplinary collaborations with experts in biopharmaceutics , veterinary medicine , and environmental toxicology . Recent publications emphasize LC-MS/MS method development for PROTACs , lipidomics in cancer therapy , and metabolomics of arginine derivatives in pregnancy complications . His work includes environmental biodegradation studies using Trametes versicolor and chiral separations via supercritical fluid chromatography .
Philip Marriott is a Professor in the School of Chemistry at Monash University, specializing in Analytical Chemistry with a focus on gas chromatography, particularly multidimensional GC and comprehensive 2D GC coupled with mass spectrometry. He has held academic positions at the National University of Singapore and RMIT University, and previously worked at the University of Bristol as a postdoctoral researcher. His research spans essential oils analysis, pollutant detection, food analysis, and HPLC applications. He leads a research group with a dedicated webpage for methodologies, publications, and collaborations. Marriott has been recognized with prestigious awards, including the Halász Medal (2021), COLACRO Medal (2019), and FACS Foundation Lectureship (2017). He holds visiting professorships at UCSI University (Malaysia) and has presented lectures globally. His work contributes to UN Sustainable Development Goals related to clean water, sustainable cities, and responsible consumption. Recent research highlights include advancements in enantioselective separations via chiral membranes and the application of GC×GC in metabolomics and drug discovery. He supervises PhD projects on essential oils, advanced GC methods, and pollutant analysis. Collaborations span institutions in Brazil, Korea, and China, reflecting his international impact in chromatography.
Xiangyu Chen is a Lecturer at the Department of Civil, Environmental and Geomatic Engineering, ETH Zürich. He is affiliated with the Luftqualität u. Partikeltechnolog (Air Quality and Particle Technology) research group. His contact information includes the email xiangchen@ethz.ch and is located at HIF D 27.1, Laura-Hezner-Weg 7, 8093 Zürich, Switzerland. His research focuses on nanotechnology and materials science applied to environmental engineering, biomedical diagnostics, and energy systems. Key areas include: Development of advanced sensors for air quality and biomedical applications Catalytic material design for energy efficiency Biomedical nanomaterials for targeted drug delivery and imaging Xiangyu Chen’s recent publications (2021–2024) highlight innovations in nanoparticle-based technologies, including 3D metal-organic frameworks for energy systems, deformable organosilica nanoparticles for MRI contrast agents, and real-time in vivo imaging techniques for glioma targeting. His work bridges theoretical material science with practical sensor and medical applications. No scientific awards or grants are explicitly mentioned. He mentors students within his teaching role but no specific advisees are listed. His affiliation with the Air Quality and Particle Technology group aligns with environmental nanotechnology research.
Claudiu Gradinaru is an Interim Chair and Professor in the Department of Chemical and Physical Sciences at the University of Toronto Mississauga, part of the Faculty of Arts & Science. He holds a Ph.D. in Physics from VU University Amsterdam and has conducted postdoctoral research at Leiden University and Sandia National Laboratories. His research focuses on single-molecule biophysics, intrinsically disordered proteins (IDPs), and G protein-coupled receptors (GPCRs), leveraging advanced microscopy and computational techniques. Education: B.Sc. in Physics (University of Bucharest, 1995), Ph.D. in Physics (VU University Amsterdam, 2001). Roles: Interim Chair, Principal Investigator of the Gradinaru Biophysics Lab, and educator in molecular biophysics, optics, and classical mechanics. Research Interests: His lab employs ultrasensitive optical techniques (e.g., single-molecule fluorescence spectroscopy) to study conformational dynamics of IDPs and GPCRs in live cells. Key areas include: Structural ensembles of IDPs using NMR, SAXS, and smFRET. GPCR oligomerization and signaling dynamics. Development of computational methods for ensemble modeling. Advising: Gradinaru mentors numerous graduate and undergraduate students, including PhD candidates Xiaohan Zhou (GPCR dynamics) and Maria Shemeteva (GPCR signaling), and MSc students Aiyan Brown (smFRET analysis) and Xinge Liu (IDP complexes). His lab has produced over 40 publications since 2001, with recent work featured in Biophysical Journal , Journal of the American Chemical Society , and Nucleic Acids Research . Labs & Instruments: The Gradinaru Lab houses custom-built microscopes for multiparameter single-molecule fluorescence, fluorescence correlation spectroscopy, and TIRF microscopy. Collaborations span institutions in Canada, the U.S., the U.K., and Australia.
